Bristol-Myers Squibb Co (NYSE:BMY)
| 63.82 Delayed Data As of Dec 13 |  -0.12 / -0.19%Today’s Change | 42.48 Today|||52-Week Range 64.75 | +22.78% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Leung Sandra General Counsel & EVP |  Sale | 2/28/2019 | 109,854 | $51.86 | $5.7M | +23.54% |
Leung Sandra General Counsel & EVP |  Buy | 2/28/2019 | 169,893 | $17.51 | $3.0M | +23.54% |
Bancroft Charles A Chief Financial Officer & Executive Vice President | Sale | 2/28/2019 | 29,813 | $51.93 | $1.5M | +23.54% |
Schmukler Louis S President-Global Manufacturing & Supply | Sale | 11/05/2019 | 25,000 | $56.56 | $1.4M | +13.18% |
Bancroft Charles A Chief Financial Officer & Executive Vice President | Buy | 2/28/2019 | 52,884 | $17.51 | $926.0K | +23.54% |
Elicker John E | Sale | 11/05/2019 | 15,000 | $56.66 | $849.9K | +13.18% |
Samuels Theodore Rapp Director | Buy | 5/16/2019 | 5,000 | $47.29 | $236.5K | +35.44% |
Lynch Thomas James Jr Chief Scientific Officer & EVP | Sale | 4/03/2019 | 3,351 | $46.88 | $157.1K | +36.13% |
Santiago Karen Murphy Controller | Sale | 5/16/2019 | 3,065 | $47.56 | $145.8K | +35.44% |
Caforio Giovanni Chairman & Chief Executive Officer | Sale | 5/05/2019 | 2,774 | $48.62 | $134.9K | +32.68% |
Page of 3